Фармсинтез logo
Фармсинтез LIFE

Фармсинтез Finanzdaten 2007-2025 | LIFE

Schlüsselkennzahlen Фармсинтез

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 2008 2007

Operating Cash Flow Per Share

-0.011 -0.208 -0.773 -0.321 -0.054 -0.498 -3.81 -1.34 -5.89 -3.27 -1.65 0.178 - - - -

Free Cash Flow Per Share

-0.023 -0.209 -0.805 -0.369 -0.12 -0.586 -4.03 -1.44 -6.46 -4.43 -2.67 -0.095 -0.046 -0.04 -0.03 -

Cash Per Share

0.031 0.045 0.035 0.246 0.051 1.37 3.02 2.03 1.25 5.16 1.08 1.15 1.55 0.18 0.031 0.049

Price To Sales Ratio

3.33 3.85 5.55 4.29 5.75 4.58 3.79 4.95 4.8 7.48 3.08 14.8 25.4 13.1 16.6 17.4

Dividend Yield

- - - - - - - - - - - - - - - -

Payout Ratio

- - - - - - - - - - - - - - - -

Revenue Per Share

1.26 1.46 1.23 0.967 0.974 2.62 4.36 2.18 2.65 2.27 3.77 1.37 0.915 1.83 1.44 1.38

Net Income Per Share

-0.69 -2.32 -1.74 -6.02 0.207 -9.13 -5.92 -2.34 -1.43 -1.37 -0.771 0.047 0.063 0.112 0.017 0.135

Book Value Per Share

0.403 1.15 3.37 13.9 16.9 6.46 32.9 14 16.2 16 9.85 2.75 0.962 2.17 2.13 2.11

Tangible Book Value Per Share

-0.701 -0.183 1.98 12.6 15.5 2.59 24.8 11.8 13.9 12.9 8.94 1.68 0.955 2.15 2.11 2.09

Shareholders Equity Per Share

0.403 1.15 3.37 13.9 16.9 6.37 30.3 14 16.2 16 9.85 2.75 0.962 2.17 2.13 2.11

Interest Debt Per Share

2.62 2.47 2.17 0.544 0.1 0.858 1.5 1.96 0.256 3.24 0.667 0.03 0.004 0.199 0.214 0.065

Market Cap

1.26 B 1.69 B 2.06 B 1.25 B 1.62 B 3.31 B 2.5 B 1.64 B 1.81 B 1.83 B 820 M 6.09 B 7 B 3 B 3 B 3 B

Enterprise Value

2 B 2.38 B 2.68 B 1.35 B 1.64 B 3.22 B 2.36 B 1.93 B 1.74 B 1.68 B 794 M 6.1 B 6.99 B 2.99 B 3.02 B 3 B

P/E Ratio

-6.09 -2.42 -3.93 -0.689 27.1 -1.31 -2.79 -4.62 -8.85 -12.4 -15 435 367 213 1.41 K 178

P/OCF Ratio

-377 -26.9 -8.86 -12.9 -105 -24.1 -4.34 -8.04 -2.16 -5.19 -7.05 114 - - - -

P/FCF Ratio

-185 -26.8 -8.5 -11.2 -46.5 -20.5 -4.1 -7.5 -1.97 -3.84 -4.35 -212 -504 -599 -792 -

P/B Ratio

10.4 4.89 2.03 0.298 0.332 1.88 0.544 0.769 0.783 1.06 1.18 7.37 24.2 11.1 11.3 11.4

EV/Sales

5.27 5.43 7.2 4.63 5.83 4.45 3.56 5.81 4.6 6.84 2.98 14.8 25.4 13.1 16.8 17.4

EV/EBITDA

-14.3 -3.68 -13.4 -7.03 -7.69 -3.2 -3.84 -5.29 -10.8 -14.1 -26.4 197 250 323 416 120

EV/OCF

-596 -38 -11.5 -14 -106 -23.4 -4.08 -9.46 -2.06 -4.75 -6.82 114 - - - -

Earnings Yield

-0.164 -0.413 -0.255 -1.45 0.037 -0.761 -0.359 -0.217 -0.113 -0.08 -0.066 0.002 0.003 0.005 0.001 0.006

Free Cash Flow Yield

-0.005 -0.037 -0.118 -0.089 -0.022 -0.049 -0.244 -0.133 -0.509 -0.261 -0.23 -0.005 -0.002 -0.002 -0.001 -

Debt To Equity

6.16 2.05 0.615 0.039 0.005 0.132 0.049 0.139 0.015 0.202 0.061 0.007 0.0 0.08 0.094 0.03

Debt To Assets

0.557 0.497 0.304 0.028 0.004 0.069 0.037 0.103 0.014 0.161 0.048 0.006 0.0 0.058 0.065 0.021

Net Debt To EBITDA

-5.26 -1.07 -3.08 -0.518 -0.108 0.094 0.24 -0.79 0.478 1.32 0.88 0.097 -0.412 -0.029 2.97 0.075

Current Ratio

0.169 0.208 0.454 0.266 0.384 0.974 1.8 1.92 5.32 2.55 2.01 3.67 1.13 1.49 1.37 1.21

Interest Coverage

-4.05 -4.65 -1.4 - 11.5 -634 -195 -279 -98.3 -96.7 -37.6 1 33.1 5.4 12.8 233

Income Quality

0.016 0.085 0.441 0.053 -0.259 0.048 0.611 0.512 4.23 2.3 2.13 -7.57 - - - -

Sales General And Administrative To Revenue

0.052 0.077 0.065 0.543 0.055 0.422 0.209 0.153 0.15 0.168 - - 0.121 0.138 0.167 0.134

Intangibles To Total Assets

0.248 0.281 0.204 0.069 0.063 0.317 0.199 0.118 0.132 0.152 0.073 0.316 0.002 0.006 0.007 0.007

Capex To Operating Cash Flow

-1.04 -0.004 -0.042 -0.15 -1.25 -0.177 -0.058 -0.072 -0.097 -0.354 -0.622 1.54 - - - -

Capex To Revenue

0.009 0.001 0.026 0.05 0.069 0.034 0.051 0.044 0.215 0.51 0.271 0.2 0.05 0.022 0.021 -

Capex To Depreciation

0.126 0.009 0.218 0.559 0.355 0.479 0.482 0.46 2.24 5.47 2.65 3.45 - - - -

Stock Based Compensation To Revenue

- - - - - - - - - - - - - - - -

Graham Number

2.5 7.73 11.5 43.4 8.86 36.2 63.5 27.2 22.9 22.1 13.1 1.7 1.17 2.34 0.903 2.53

Return On Invested Capital, ROIC

-0.192 -0.153 -0.025 -0.477 0.423 -1.16 -0.11 -0.22 -0.091 -0.083 -0.216 0.002 0.101 0.126 0.027 0.081

Return On Tangible Assets, ROTA

-0.206 -0.681 -0.321 -0.331 0.01 -1.1 -0.183 -0.14 -0.093 -0.08 -0.067 0.02 0.021 0.038 0.006 0.045

Graham Net Net

-3.95 -3.48 -3.3 -5.1 -5.09 -2.8 -1 -0.015 0.202 2.53 0.507 0.633 -0.347 -0.393 -0.658 -0.626

Working Capital

-977 M -787 M -560 M -1.09 B -811 M -30.2 M 768 M 677 M 959 M 675 M 187 M 470 M 76.5 M 51.3 M 43 M 23.3 M

Tangible Asset Value

-211 M -55.2 M 596 M 3.78 B 4.47 B 715 M 3.76 B 1.79 B 1.98 B 1.39 B 632 M 507 M 287 M 268 M 263 M 261 M

Net Current Asset Value, NCAV

-1.02 B -874 M -573 M -1.29 B -1.12 B -477 M 590 M 675 M 953 M 671 M 186 M 459 M 73.1 M 50.7 M 38.9 M 21.6 M

Invested Capital

-300 M -59.9 M 210 M -366 M -72.1 M 1.45 B 2.39 B 1.45 B 1.76 B 1.41 B 588 M 838 M 271 M 248 M 253 M 249 M

Average Receivables

- - - - 222 M 517 M 507 M 212 M 78 M 154 M 76.1 M - - - - -

Average Payables

160 M 160 M 210 M 379 M 481 M 2.68 B 2.54 B 154 M 90.8 M 91.6 M 65.2 M 32.1 M 68.8 M 78.9 M 91.5 M -

Average Inventory

39.1 M 52.9 M 111 M 212 M 238 M 189 M 198 M 190 M 117 M 71.5 M 64.6 M 71 M 71.7 M 67.3 M 62.1 M -

Days Sales Outstanding

- - - - - 224 326 466 - 232 209 - - - - -

Days Payables Outstanding

218 186 306 336 753 392 6.61 K 390 285 125 323 - 138 173 308 385

Days Of Inventory On Hand

51.2 47.6 120 213 393 182 230 489 344 186 159 80.4 166 157 248 219

Receivables Turnover

- - - - - 1.63 1.12 0.783 - 1.57 1.75 - - - - -

Payables Turnover

1.67 1.96 1.19 1.09 0.485 0.932 0.055 0.936 1.28 2.93 1.13 - 2.64 2.11 1.19 0.949

Inventory Turnover

7.12 7.66 3.04 1.71 0.929 2.01 1.58 0.746 1.06 1.97 2.29 4.54 2.2 2.32 1.47 1.66

Return On Equity, ROE

-1.71 -2.02 -0.518 -0.433 0.012 -1.43 -0.195 -0.167 -0.088 -0.086 -0.078 0.017 0.066 0.052 0.008 0.064

Capex Per Share

0.012 0.001 0.032 0.048 0.067 0.088 0.221 0.096 0.569 1.16 1.02 0.273 0.046 0.04 0.03 -

Alle Zahlen in RUB-Währung

Schlüsselkennzahlen Vierteljährlich Фармсинтез

2023-Q2 2022-Q4 2022-Q2 2021-Q4 2021-Q2 2020-Q4 2020-Q2 2019-Q4 2019-Q2 2018-Q4 2018-Q2 2017-Q4 2017-Q2 2016-Q4 2016-Q2 2015-Q4 2015-Q2 2014-Q4 2014-Q2 2013-Q4 2013-Q2 2012-Q4 2011-Q4 2011-Q2 2010-Q4 2010-Q2 2009-Q4 2009-Q2 2008-Q4 2008-Q2

Operating Cash Flow Per Share

-0.001 0.0 -0.0 -0.118 -0.09 -0.469 -0.308 -0.082 -0.144 -0.0 -0.0 0.0 -0.0 -0.003 0.0 -0.001 -0.0 -0.003 -0.003 -1.43 -1.91 -1.25 0.089 0.089 - - - - - -

Free Cash Flow Per Share

-0.001 0.0 -0.0 -0.119 -0.091 -0.489 -0.32 -0.132 -0.144 -0.0 -0.0 0.0 -0.0 -0.003 0.0 -0.001 -0.0 -0.003 -0.003 -1.94 -2.58 -1.69 -0.048 -0.048 -0.023 -0.023 -0.02 -0.02 -0.008 -0.015

Cash Per Share

0.848 0.145 0.003 0.045 0.04 0.035 0.06 0.231 0.043 0.016 0.837 1.51 0.297 3.02 0.818 2.27 1.49 1.25 2.99 4.52 9.62 1.08 1.15 1.35 1.55 0.812 0.18 0.106 - 0.04

Price To Sales Ratio

13.2 7.22 5.86 7.8 8.41 8.99 13.8 12.8 8.46 6.71 21.1 7.92 10.8 5.35 12.6 13.2 7.75 9.6 10.5 8.08 38.1 6.16 29.6 34 50.8 52.5 26.2 26.2 34.7 33.3

Dividend Yield

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Payout Ratio

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Revenue Per Share

0.569 0.582 0.691 0.719 0.737 0.762 0.477 0.325 0.631 0.835 0.345 1.51 1.14 3.08 1.27 0.818 1.63 1.32 1.32 2.1 0.506 1.88 0.684 0.684 0.457 0.457 0.915 0.915 0.691 0.721

Net Income Per Share

-0.54 -0.475 -0.224 -1.48 -0.839 -1.39 -0.361 -6.1 -0.13 -0.107 -1.28 -4.05 -5 -7.6 3.38 -0.472 -1.87 -0.717 -0.717 1.26 -1.64 -0.386 0.023 0.023 0.032 0.032 0.056 0.056 0.068 0.009

Book Value Per Share

2.1 0.41 1.15 1.15 2.48 3.37 4.67 4.7 14.5 11.8 4.48 7.1 8.49 32.8 16.9 14 13.2 16.2 13 14 16.1 9.85 2.75 1.85 0.962 0.93 2.17 2.15 - 2.12

Tangible Book Value Per Share

0.801 -0.929 -0.17 -0.183 1.2 2.21 3.47 3.46 13.3 10.5 0.878 2.85 7.38 24.8 14.7 11.8 11 13.9 12.8 11.3 15.2 8.94 1.68 1.32 0.955 0.923 2.15 2.13 - 2.1

Shareholders Equity Per Share

2.1 0.41 1.15 1.15 2.48 3.37 4.67 4.7 14.5 11.8 4.48 7.01 8.49 30.3 16.9 14 13.2 16.2 13 14 16.1 9.85 2.75 1.85 0.962 0.93 2.17 2.15 - 2.12

Interest Debt Per Share

2.51 2.53 2.06 2.35 1.44 1.34 0.922 0.878 0.115 1.14 0.986 0.925 1.97 1.48 3.91 1.94 0.14 0.249 0.254 2.82 0.819 0.633 0.025 0.015 0.002 0.038 0.186 0.2 - 0.139

Market Cap

2.28 B 1.24 B 1.22 B 1.69 B 1.87 B 2.06 B 1.96 B 1.2 B 1.67 B 1.64 B 2.2 B 3.01 B 3.69 B 2.51 B 2.43 B 1.64 B 1.91 B 1.81 B 1.98 B 2.1 B 1.78 B 820 M 6.09 B 7.01 B 7 B 7.22 B 3 B 3 B 3 B 3 B

Enterprise Value

2.79 B 1.98 B 1.82 B 2.38 B 2.29 B 2.45 B 2.22 B 1.39 B 1.7 B 1.97 B 2.29 B 2.92 B 4.28 B 2.36 B 3.02 B 1.93 B 1.92 B 1.74 B 1.62 B 1.94 B 967 M 794 M 6.1 B 7 B 6.99 B 7.22 B 2.99 B 3.01 B - 3.01 B

P/E Ratio

-3.49 -2.21 -4.52 -0.948 -1.85 -1.24 -4.56 -0.17 -10.3 -13.1 -1.43 -0.741 -0.612 -0.543 1.19 -5.72 -1.69 -4.43 -4.82 3.38 -2.94 -7.52 218 250 184 189 107 107 88.8 705

P/OCF Ratio

-6.61 K 63 K -53 K -47.6 -68.6 -14.6 -21.4 -50.3 -37 -21.4 K -61.5 K 338 K -25.2 K -5.78 K 59.8 K -10.4 K -42.2 K -4 K -5.09 K -11.9 -10.1 -9.28 228 262 - - - - - -

P/FCF Ratio

-6 K 68.7 K -49.1 K -47.3 -68.4 -14 -20.6 -31.3 -37 -22.7 K -36.8 K 1.25 M -24.7 K -5.65 K 62.2 K -9.59 K -40.7 K -3.66 K -4.62 K -8.77 -7.45 -6.86 -424 -488 -1.01 K -1.04 K -1.2 K -1.2 K -3.17 K -1.58 K

P/B Ratio

3.59 10.2 3.54 4.89 2.5 2.03 1.41 0.883 0.368 0.473 1.63 1.71 1.44 0.545 0.952 0.771 0.961 0.783 1.07 1.22 1.2 1.18 7.37 12.6 24.2 25.8 11.1 11.2 - 11.3

EV/Sales

16.2 11.5 8.75 11 10.3 10.7 15.6 14.8 8.64 8.05 22 7.67 12.5 5.04 15.7 15.5 7.79 9.19 8.6 7.47 20.7 5.96 29.6 34 50.8 52.4 26.2 26.3 - 33.4

EV/EBITDA

-72.6 -33.3 -487 -5.39 -10 -8 -24.6 -8.72 -53 2.51 -2.27 -1.12 -4.9 -0.902 -11.3 -7.63 -7.26 -21.6 -20.2 -16.8 -42.6 -52.9 393 452 499 515 647 649 - 830

EV/OCF

-8.07 K 100 K -79 K -67.1 -84.1 -17.4 -24.2 -58.2 -37.8 -25.7 K -63.8 K 328 K -29.2 K -5.44 K 74.2 K -12.2 K -42.4 K -3.84 K -4.18 K -11 -5.48 -8.99 228 262 - - - - - -

Earnings Yield

-0.072 -0.113 -0.055 -0.264 -0.135 -0.202 -0.055 -1.47 -0.024 -0.019 -0.175 -0.337 -0.408 -0.461 0.211 -0.044 -0.148 -0.056 -0.052 0.074 -0.085 -0.033 0.001 0.001 0.001 0.001 0.002 0.002 0.003 0.0

Free Cash Flow Yield

-0.0 0.0 -0.0 -0.021 -0.015 -0.071 -0.049 -0.032 -0.027 -0.0 -0.0 0.0 -0.0 -0.0 0.0 -0.0 -0.0 -0.0 -0.0 -0.114 -0.134 -0.146 -0.002 -0.002 -0.001 -0.001 -0.001 -0.001 -0.0 -0.001

Debt To Equity

1.2 6.16 1.75 2.05 0.578 0.396 0.198 0.187 0.008 0.096 0.22 0.132 0.232 0.049 0.232 0.139 0.011 0.015 0.019 0.202 0.051 0.061 0.007 0.005 0.0 0.039 0.08 0.087 - 0.062

Debt To Assets

0.444 0.557 0.446 0.497 0.232 0.196 0.111 0.105 0.006 0.073 0.095 0.069 0.164 0.037 0.164 0.103 0.009 0.014 0.017 0.161 0.039 0.048 0.006 0.003 0.0 0.017 0.058 0.061 - 0.043

Net Debt To EBITDA

-13.1 -12.4 -161 -1.57 -1.84 -1.28 -2.85 -1.18 -1.12 0.418 -0.084 0.036 -0.672 0.056 -2.2 -1.14 -0.033 0.956 4.39 1.36 35.8 1.76 0.194 -0.276 -0.825 -0.422 -0.058 2.3 - 3.23

Current Ratio

0.542 0.169 0.25 0.208 0.303 0.454 0.516 0.505 0.266 0.578 0.695 0.974 1.16 1.8 1.16 1.92 3.74 5.32 7.35 2.55 2.9 2.01 3.67 1.7 1.13 1.18 1.49 1.43 - 1.29

Interest Coverage

- - -3.45 - - - - - - - - - - - - - - -98.3 -98.3 - - -37.6 1 1 33.1 33.1 5.4 5.4 233 12.8

Income Quality

2.11 -0.14 0.341 0.08 0.108 0.338 0.852 0.014 1.11 2.44 0.093 -0.009 0.097 0.376 0.079 2.21 0.16 3.6 4.91 -1.14 K 5.95 2.3 -7.57 -7.57 - - - - - -

Sales General And Administrative To Revenue

0.525 0.405 0.202 0.193 0.197 0.201 0.274 0.587 0.522 0.48 1.02 0.638 0.965 0.579 0.349 0.625 0.344 0.15 0.15 0.408 0.458 - - - 0.121 0.121 0.138 0.138 0.134 0.167

Intangibles To Total Assets

0.23 0.295 0.293 0.281 0.207 0.17 0.144 0.148 0.063 0.084 0.348 0.317 0.092 0.199 0.092 0.118 0.144 0.132 0.009 0.152 0.042 0.073 0.316 0.168 0.002 0.004 0.006 0.007 - 0.007

Capex To Operating Cash Flow

-0.101 0.083 -0.08 -0.006 -0.003 -0.043 -0.039 -0.606 - -0.06 -0.668 0.729 -0.02 -0.022 0.04 -0.082 -0.036 -0.093 -0.101 -0.354 -0.354 -0.354 1.54 1.54 - - - - - -

Capex To Revenue

0.0 0.0 0.0 0.001 0.0 0.027 0.025 0.154 - 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.241 1.34 0.235 0.2 0.2 0.05 0.05 0.022 0.022 0.011 0.021

Capex To Depreciation

2.86 0.104 0.157 0.013 0.004 0.231 0.199 34.6 - 0.17 0.868 0.299 0.102 0.276 0.043 0.837 0.102 1.73 3.27 5.23 5.23 5.23 3.45 3.45 - - - - - -

Stock Based Compensation To Revenue

- - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

Graham Number

5.05 2.09 2.4 6.18 6.84 10.3 6.16 25.4 6.52 5.34 11.4 25.3 30.9 72 35.8 12.2 23.5 16.2 14.5 19.9 24.3 9.24 1.2 0.985 0.828 0.814 1.66 1.65 - 0.637

Return On Invested Capital, ROIC

-0.103 -0.089 -0.114 -0.105 -0.168 -0.061 -0.03 -1.13 -0.04 0.02 -0.149 -0.236 -0.15 -0.242 0.22 -0.155 -0.141 -0.046 -0.057 -0.065 -0.019 -0.108 0.001 0.001 0.05 0.05 0.063 0.063 - 0.014

Return On Tangible Assets, ROTA

-0.124 -0.149 -0.071 -0.434 -0.171 -0.245 -0.051 -0.857 -0.007 -0.008 -0.19 -0.441 -0.46 -0.235 0.156 -0.028 -0.144 -0.046 -0.051 0.085 -0.08 -0.033 0.01 0.009 0.011 0.015 0.019 0.019 - 0.003

Graham Net Net

-2.04 -3.73 -2.79 -3.48 -2.95 -2.57 -2.43 -3.3 -4.48 -2.71 -3.93 -3.03 -2.89 -1.51 -4.83 -1.12 1.38 0.202 2.26 1.27 4.88 -1.11 0.633 0.143 -0.347 -0.255 -0.393 -0.526 - -0.642

Working Capital

-475 M -977 M -703 M -787 M -742 M -560 M -475 M -456 M -1.15 B -428 M -383 M -30.2 M 167 M 768 M 167 M 677 M 816 M 959 M 983 M 675 M 895 M 187 M 470 M 273 M 76.5 M 63.9 M 51.3 M 47.1 M - 33.2 M

Tangible Asset Value

243 M -274 M -51.3 M -55.2 M 362 M 664 M 1.03 B 1.01 B 4.14 B 3.09 B 265 M 715 M 2.22 B 3.76 B 2.22 B 1.79 B 1.66 B 1.98 B 1.83 B 1.39 B 1.4 B 632 M 507 M 397 M 287 M 278 M 268 M 266 M - 262 M

Net Current Asset Value, NCAV

-516 M -1.02 B -771 M -874 M -793 M -573 M -580 M -597 M -1.23 B -491 M -898 M -477 M 166 M 590 M 166 M 675 M 808 M 953 M 971 M 671 M 887 M 186 M 459 M 266 M 73.1 M 61.9 M 50.7 M 44.8 M - 30.2 M

Invested Capital

260 M -237 M 7.53 M -59.9 M -18.3 M 142 M 243 M 274 M -435 M 333 M 1.1 B 1.45 B 913 M 2.39 B 913 M 1.45 B 1.6 B 1.76 B 1.45 B 1.41 B 1.35 B 588 M 838 M 554 M 271 M 259 M 248 M 251 M - 251 M

Average Receivables

143 M 132 M 96.4 M 118 M 264 M 344 M 198 M 76 M 195 M 273 M 385 M 230 M 244 M 314 M 144 M 195 M 120 M - - - - - - - - - - - - -

Average Payables

239 M 284 M 266 M 179 M 420 M 659 M 469 M 665 M 688 M 387 M 385 M 243 M 240 M 240 M 224 M 200 M 142 M 121 M 86.5 M 220 M 255 M - 16.1 M 48.2 M 66.5 M 71.1 M 76.1 M 81.7 M - -

Average Inventory

63.5 M 40.2 M 37.3 M 55.2 M 71.9 M 80.4 M 84.2 M 159 M 218 M 198 M 204 M 196 M 179 M 179 M 206 M 221 M 186 M 140 M 102 M 80.8 M 73.5 M - 68 M 74 M 74.3 M 69.1 M 66.9 M 67.7 M - -

Days Sales Outstanding

112 37.8 83.5 - 95.6 114 251 - 69.5 87.1 267 109 - 93.9 65 107 87.6 - - - - - - - - - - - - -

Days Payables Outstanding

227 106 238 76.6 176 421 796 148 850 205 317 213 55.6 1.58 K 73.1 143 47.3 141 123 22.9 1.04 K 159 - 19.6 68.2 73 85.4 91.9 - 164

Days Of Inventory On Hand

64.4 25 23.4 19.6 60 47.1 104 47.3 188 139 131 154 51.1 971 67.1 131 66.3 170 137 29.9 227 78.5 39.7 43.3 81.7 76.1 77.5 78.4 - 112

Receivables Turnover

0.803 2.38 1.08 - 0.941 0.788 0.359 - 1.29 1.03 0.337 0.827 - 0.958 1.38 0.837 1.03 - - - - - - - - - - - - -

Payables Turnover

0.397 0.846 0.378 1.17 0.513 0.214 0.113 0.609 0.106 0.439 0.284 0.423 1.62 0.057 1.23 0.627 1.9 0.64 0.731 3.93 0.086 0.565 - 4.59 1.32 1.23 1.05 0.979 - 0.548

Inventory Turnover

1.4 3.6 3.85 4.59 1.5 1.91 0.863 1.9 0.48 0.646 0.685 0.583 1.76 0.093 1.34 0.685 1.36 0.531 0.659 3.01 0.396 1.15 2.27 2.08 1.1 1.18 1.16 1.15 - 0.807

Return On Equity, ROE

-0.257 -1.16 -0.196 -1.29 -0.338 -0.411 -0.077 -1.3 -0.009 -0.009 -0.286 -0.578 -0.589 -0.251 0.201 -0.034 -0.142 -0.044 -0.055 0.09 -0.102 -0.039 0.008 0.013 0.033 0.034 0.026 0.026 - 0.004

Capex Per Share

0.0 0.0 0.0 0.001 0.0 0.02 0.012 0.05 - 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.507 0.676 0.443 0.137 0.137 0.023 0.023 0.02 0.02 0.008 0.015

Alle Zahlen in RUB-Währung